Neupath Health Stock EBITDA
| NPTH Stock | CAD 0.16 0.01 5.88% |
NeuPath Health fundamentals help investors to digest information that contributes to NeuPath Health's financial success or failures. It also enables traders to predict the movement of NeuPath Stock. The fundamental analysis module provides a way to measure NeuPath Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeuPath Health stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -671.6 K | -705.2 K |
NeuPath | EBITDA |
NeuPath Health Company EBITDA Analysis
NeuPath Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current NeuPath Health EBITDA | 2.07 M |
Most of NeuPath Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NeuPath Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
NeuPath Ebitda
Ebitda |
|
According to the company disclosure, NeuPath Health reported earnings before interest,tax, depreciation and amortization of 2.07 M. This is 99.76% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all Canada stocks is 99.95% higher than that of the company.
NeuPath EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeuPath Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NeuPath Health could also be used in its relative valuation, which is a method of valuing NeuPath Health by comparing valuation metrics of similar companies.NeuPath Health is currently under evaluation in ebitda category among its peers.
NeuPath Fundamentals
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | 0.0146 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 17.82 M | ||||
| Shares Outstanding | 56.39 M | ||||
| Shares Owned By Insiders | 0.98 % | ||||
| Shares Owned By Institutions | 24.24 % | ||||
| Number Of Shares Shorted | 158 | ||||
| Price To Book | 0.41 X | ||||
| Price To Sales | 0.13 X | ||||
| Revenue | 66.1 M | ||||
| Gross Profit | 10.82 M | ||||
| EBITDA | 2.07 M | ||||
| Net Income | (107 K) | ||||
| Cash And Equivalents | 7.48 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 195 K | ||||
| Debt To Equity | 0.67 % | ||||
| Current Ratio | 1.27 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | 3.03 M | ||||
| Target Price | 0.5 | ||||
| Number Of Employees | 156 | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 9.02 M | ||||
| Total Asset | 41.78 M | ||||
| Retained Earnings | (26.02 M) | ||||
| Working Capital | 1.51 M | ||||
| Net Asset | 41.78 M |
About NeuPath Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeuPath Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuPath Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuPath Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.